Angelman syndrome patients who experience falls or sleep problems tend to have worse quality of life, according to a…
Marisa Wexler, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
The protein Ube3a, whose defect causes Angelman syndrome, helps regulate connections between brain cells during development. That’s according to…
Combining outcomes at clinic visits with those of at-home monitoring may be an effective way of determining an experimental treatment’s…
Two new standardized tools to measure the severity of Angelman syndrome (AS) in children — one based on clinician…
A team of scientists in Italy has developed new nanoparticles that could deliver therapies to the brain through the nose.
Following lackluster data in Phase 1 testing, Roche announced it will not initiate new trials of the experimental therapy rugonersen…
Parents of children with Angelman syndrome are less economically productive, which results in millions of dollars of lost productivity…
The Angelman Syndrome Alliance (ASA) is currently accepting grant applications from scientists who are doing basic research to enhance…
Spinal surgery for scoliosis carries a high likelihood of complications, including serious ones, among people with Angelman syndrome and…
The UBE3A protein is needed shortly after birth for the proper development of the dorsomedial striatum, part of a brain…